Skip to main content
Article
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: Results of a phase II study
Cancer Journal (2000)
  • Dan L. Longo, National Institutes of Health
  • Patricia L. Duffey, National Institutes of Health
  • John G. Gribben, Harvard University
  • Elaine S. Jaffe, National Institutes of Health
  • Brendan D. Curti, National Institutes of Health
  • Barry L. Gause, National Institutes of Health
  • John E. Janik, National Institutes of Health
  • Virginia M. Braman, ImmunoGen, Inc.
  • Dixie Esseltine, ImmunoGen, Inc.
  • Wyndham H. Wilson, National Institutes of Health
  • Dwight Kaufman, National Institutes of Health
  • Robert E. Wittes, National Institutes of Health
  • Lee M. Nadler, Harvard University
  • Walter J. Urba, National Institutes of Health
Publication Date
January 1, 2000
Citation Information
Dan L. Longo, Patricia L. Duffey, John G. Gribben, Elaine S. Jaffe, et al.. "Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: Results of a phase II study" Cancer Journal Vol. 6 Iss. 3 (2000) p. 146 - 150
Available at: http://works.bepress.com/walter-urba/25/